Acasti pharma to attend bio international convention 2024

Princeton, n.j., may 28, 2024 (globe newswire) -- acasti pharma inc. (nasdaq: acst) (acasti or the company), a late-stage, biopharma company advancing gtx-104, its novel, injectable formulation of nimodipine that addresses high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage (asah), today announced that the company will be participating in the bio international convention taking place at the san diego convention center from june 3-6, 2024.
ACST Ratings Summary
ACST Quant Ranking